$DVAX Highlights
•
HEPLISAV-B is a 2-dose Hepatitis B virus vaccine recently available in the US.

•
HEPLISAV-B offers earlier and higher levels of seroprotection than 3-dose Engerix-B.

•
HEPLISAV-B was cost-effective vs Engerix-B for multiple high-risk adult populations.

•
HEPLISAV-B was cost-effective for universal vaccination of adults.

https://www.sciencedirect.com/science/article/pii/S0264410X2100582X?via%3Dihub
<ticker> highlights heplisav - b is a <number> - dose hepatitis b virus vaccine recently available in the us . heplisav - b offers earlier and higher levels of seroprotection  than <number> - dose engerix - b . heplisav - b was cost - effective <ticker> engerix - b for multiple high - risk adult populations . heplisav - b was cost - effective for universal vaccination of adults .